HIV protease inhibitors

Details HIV protease inhibitors HIV protease inhibitors

2011-03-01

2011-03-01

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S526000

Reexamination Certificate

active

07897635

ABSTRACT:
Compounds useful for inhibiting HIV protease are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating wild-type HIV and of multidrug-resistant strains of HIV, also are disclosed.

REFERENCES:
patent: 5196438 (1993-03-01), Martin et al.
patent: 5475027 (1995-12-01), Talley et al.
patent: 5502060 (1996-03-01), Thompson et al.
patent: 5585357 (1996-12-01), Dolle et al.
patent: 5691372 (1997-11-01), Tung et al.
patent: 5703076 (1997-12-01), Talley et al.
patent: 5705500 (1998-01-01), Getman et al.
patent: 5723490 (1998-03-01), Tung
patent: 5728718 (1998-03-01), Randad et al.
patent: 5753660 (1998-05-01), Sikorski et al.
patent: 5843946 (1998-12-01), Vazquez et al.
patent: 5968942 (1999-10-01), Vazquez et al.
patent: 5990155 (1999-11-01), Tung et al.
patent: 6008228 (1999-12-01), Bailey et al.
patent: 6060476 (2000-05-01), Vazquez et al.
patent: 6100277 (2000-08-01), Tucker et al.
patent: 6245806 (2001-06-01), Dombrowski et al.
patent: 6248775 (2001-06-01), Vazquez et al.
patent: 6319946 (2001-11-01), Hale et al.
patent: 7157489 (2007-01-01), Ghosh et al.
patent: 0715618 (1996-06-01), None
patent: 1136479 (2001-09-01), None
patent: WO-9404492 (1994-03-01), None
patent: WO-9414793 (1994-07-01), None
patent: WO-9506030 (1995-03-01), None
patent: WO-9628463 (1996-09-01), None
patent: WO-9633184 (1996-10-01), None
patent: WO-9719055 (1997-05-01), None
patent: WO-9965870 (1999-12-01), None
patent: WO-9967254 (1999-12-01), None
patent: WO-0125240 (2001-04-01), None
patent: WO-02081478 (2002-10-01), None
patent: WO-02083657 (2002-10-01), None
patent: WO-02092595 (2002-11-01), None
Vippagunta et al., Crystalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Bundgaard, Design of Prodrugs: Introduction, p. 1, 1985.
Silverman, Prodrugs and Drug Delivery Systems, The Organic Chemistry of Drug Design and Drug Action, pp. 352-400, 1992.
Beaulieu et al., J. Med. Chem., 43, pp. 1094-1108 (2000).
Ghosh et al., Bioorganic & Medicinal Chemistry Letters 8, pp. 687-690 (1998).
Ghosh et al., J. Med. Chem., 39, pp. 3278-3290 (1996).
Marcus et al., PubMed Abstract (Intervirology, 45(4-6):260-6), 2002.
Miles, Medline Abstract (Community Pract, vol. 78, Issue 8, pp. 292-294) Aug. 2005.
Spradling et al.,Clinical Infectious Diseases, 35(9), 1106-1112 (2002).
van Heeswijk et al., PubMed Abstract (Antivir Ther. 6(4):201-29), Dec. 2001.

Affiliated with

Also associated with

Rating

HIV protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2677244